Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Gaiddon

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Cancers|November 10, 2019
HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK PathwayMarie-Elodie Spaety, Alexandre Gries, Amandine Badie, et al.
Oncotarget|December 10, 2016
A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatinCynthia Licona, Marie-Elodie Spaety, Antonelle Capuozzo, et al.
Journal of Inorganic Biochemistry|March 5, 2023
Multifunctional metallochaperone modifications for targeting subsite cavities in mutant p53-Y220CJessica J Miller, Kalvin Kwan, Anaïs Blanchet, et al.
Oncogene|November 14, 2020
The atypical cadherin MUCDHL antagonizes colon cancer formation and inhibits oncogenic signaling through multiple mechanismsMarine Beck, Mathilde Baranger, Ahlam Moufok-Sadoun, et al.
Cancer Letters|January 30, 2024
The unfolded protein response-glutathione metabolism axis: A novel target of a cycloruthenated complexes bypassing tumor resistance mechanismsGilles Riegel, Christophe Orvain, Sevda Recberlik, et al.
Biochemical Pharmacology|September 12, 2012
Induction of caspase 8 and reactive oxygen species by ruthenium-derived anticancer compounds with improved water solubility and cytotoxicityVania Vidimar, Xiangjun Meng, Marcelina Klajner, et al.
Cancers|June 12, 2019
Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on <i>EREG</i>-Driven Oncogenic AddictionSylvie Job, Aurélien de Reyniès, Betty Heller, et al.
Metallomics : Integrated Biometal Science|April 13, 2024
Quest for a stable Cu-ligand complex with a high catalytic activity to produce reactive oxygen speciesMerwan Bouraguba, Adeline M Schmitt, Venkata Suseela Yelisetty, et al.
Cancer Research|June 25, 2009
A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOPXiangjun Meng, Mili L Leyva, Marjorie Jenny, et al.
Journal of Medicinal Chemistry|November 19, 2025
Inverse Correlation between Endoplasmic Reticulum Stress Intensity and Antitumor Immune Response with Ruthenium(II)-Based Photosensitizers for the Photodynamic Therapy of Head and Neck Squamous Cell CarcinomaChloé Thibaudeau, Cyril Bour, Matthieu Scarpi-Luttenauer, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Cancers|November 10, 2019
HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK PathwayMarie-Elodie Spaety, Alexandre Gries, Amandine Badie, et al.
Oncotarget|December 10, 2016
A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatinCynthia Licona, Marie-Elodie Spaety, Antonelle Capuozzo, et al.
Journal of Inorganic Biochemistry|March 5, 2023
Multifunctional metallochaperone modifications for targeting subsite cavities in mutant p53-Y220CJessica J Miller, Kalvin Kwan, Anaïs Blanchet, et al.
Oncogene|November 14, 2020
The atypical cadherin MUCDHL antagonizes colon cancer formation and inhibits oncogenic signaling through multiple mechanismsMarine Beck, Mathilde Baranger, Ahlam Moufok-Sadoun, et al.
Cancer Letters|January 30, 2024
The unfolded protein response-glutathione metabolism axis: A novel target of a cycloruthenated complexes bypassing tumor resistance mechanismsGilles Riegel, Christophe Orvain, Sevda Recberlik, et al.
Biochemical Pharmacology|September 12, 2012
Induction of caspase 8 and reactive oxygen species by ruthenium-derived anticancer compounds with improved water solubility and cytotoxicityVania Vidimar, Xiangjun Meng, Marcelina Klajner, et al.
Cancers|June 12, 2019
Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on <i>EREG</i>-Driven Oncogenic AddictionSylvie Job, Aurélien de Reyniès, Betty Heller, et al.
Metallomics : Integrated Biometal Science|April 13, 2024
Quest for a stable Cu-ligand complex with a high catalytic activity to produce reactive oxygen speciesMerwan Bouraguba, Adeline M Schmitt, Venkata Suseela Yelisetty, et al.
Cancer Research|June 25, 2009
A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOPXiangjun Meng, Mili L Leyva, Marjorie Jenny, et al.
Journal of Medicinal Chemistry|November 19, 2025
Inverse Correlation between Endoplasmic Reticulum Stress Intensity and Antitumor Immune Response with Ruthenium(II)-Based Photosensitizers for the Photodynamic Therapy of Head and Neck Squamous Cell CarcinomaChloé Thibaudeau, Cyril Bour, Matthieu Scarpi-Luttenauer, et al.
Pageof 7